Invitae Divests Ciitizen Health Data Platform and Implements Further Cost Cuts

– Maintains Minority Equity Stake in Ciitizen –

– Anticipated Total Cash Savings of Approximately $90-100 Million on an Annualized Basis –

SAN FRANCISCO, Dec. 13, 2023 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced strategic changes to streamline operations and reduce operating cash burn. The company has divested the assets of Ciitizen and announced strategic cost cuts, which will include a workforce reduction and other operating expense reductions.

Read more at prnewswire.com